Matrix metalloproteinase-9 and autoimmune diseases (Q28237731)

Journal of Clinical Immunology

Europe PubMed Central

title

Matrix metalloproteinase-9 and autoimmune diseases (English)

0 references

3

Yehuda Shoenfeld

0 references

Yaniv Sherer

series ordinal

2

object named as

Yaniv Sherer

0 references

Maya Ram

series ordinal

1

object named as

Maya Ram

0 references

language of work or name

English

0 references

publication date

July 2006

0 references

published in

0 references

volume

26

0 references

issue

4

0 references

page(s)

299-307

0 references

exact match

https://scigraph.springernature.com/pub.10.1007/s10875-006-9022-6

0 references

cites work

Hydrocortisone suppresses intranuclear activator-protein-1 (AP-1) binding activity in mononuclear cells and plasma matrix metalloproteinase 2 and 9 (MMP-2 and MMP-9).

1 reference

12 December 2020

Matrix metalloproteinase-9 and -7 are regulated in experimental autoimmune encephalomyelitis.

1 reference

12 December 2020

Expression of specific matrix metalloproteinases in inflammatory myopathies.

1 reference

12 December 2020

Gelatinase B: a tuner and amplifier of immune functions.

1 reference

12 December 2020

Immunomodulation for treatment and prevention of atherosclerosis

1 reference

12 December 2020

Expression of matrix metalloproteinase 9 and its regulators in the unstable coronary atherosclerotic plaque

1 reference

12 December 2020

Clinical implications of matrix metalloproteinases

1 reference

12 December 2020

Overexpression of MMP9 and tissue factor in unstable carotid plaques associated with Chlamydia pneumoniae, inflammation, and apoptosis.

1 reference

12 December 2020

In vitro effects of flunisolide on MMP-9, TIMP-1, fibronectin, TGF-beta1 release and apoptosis in sputum cells freshly isolated from mild to moderate asthmatics.

1 reference

12 December 2020

Matrix metalloproteinases

1 reference

12 December 2020

Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies

1 reference

12 December 2020

Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis.

1 reference

12 December 2020

Differential expression of matrix metalloproteinases in labial salivary glands of patients with primary Sjögren's syndrome

1 reference

12 December 2020

Regulation of matrix metalloproteinases: an overview

1 reference

12 December 2020

Decreased MMP-9 production in primary progressive multiple sclerosis patients

1 reference

12 December 2020

Matrix metalloproteinase (MMP)-9 type IV collagenase/gelatinase implicated in the pathogenesis of Sjögren's syndrome

1 reference

12 December 2020

Different effects of simvastatin and interferon beta on the proteolytic activity of matrix metalloproteinases

1 reference

12 December 2020

Markedly elevated serum MMP-9 (gelatinase B) levels in rheumatoid arthritis: a potentially useful laboratory marker

1 reference

12 December 2020

Gelatinase B functions as regulator and effector in leukocyte biology

1 reference

12 December 2020

Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9)

1 reference

12 December 2020

Concentrations of circulating matrix metalloproteinase 9 inversely correlate with autoimmune antibodies to double stranded DNA: implications for monitoring disease activity in systemic lupus erythematosus

1 reference

12 December 2020

The expression of matrix metalloproteinases-9, transforming growth factor-beta1 and transforming growth factor-beta receptor I in human atherosclerotic plaque and their relationship with plaque stability.

1 reference

12 December 2020

A novel and simple immunocapture assay for determination of gelatinase-B (MMP-9) activities in biological fluids: saliva from patients with Sjögren's syndrome contain increased latent and active gelatinase-B levels

1 reference

12 December 2020

Decreased MMP-9 activity in the serum of patients with diffuse cutaneous systemic sclerosis

1 reference

12 December 2020

Matrix metalloproteinase-9 and its natural inhibitor TIMP-1 expressed or secreted by peripheral blood mononuclear cells from patients with systemic lupus erythematosus

1 reference

12 December 2020

Elevated matrix metalloproteinase-9 in patients with systemic sclerosis

1 reference

12 December 2020

Intravenous gamma globulin inhibits the production of matrix metalloproteinase-9 in macrophages

1 reference

12 December 2020

Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis.

1 reference

12 December 2020

Human endothelial gelatinases and angiogenesis

1 reference

12 December 2020

Regulation of matrix biology by matrix metalloproteinases

1 reference

12 December 2020

Matrix metalloproteinases-3, -8, -9 as markers of disease activity and joint damage progression in early rheumatoid arthritis

1 reference

12 December 2020

Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury

1 reference

12 December 2020

Activity of matrix metalloproteinase-9 is elevated in sera of patients with systemic lupus erythematosus

1 reference

12 December 2020